Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C21H25BrF2O5 |
Molecular Weight | 475.321 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 8 / 8 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]3(F)[C@@]2([H])C[C@@H](F)C4=CC(=O)C(Br)=C[C@]34C
InChI
InChIKey=MYZDPUZXMFCPMU-LRIWMWCYSA-N
InChI=1S/C21H25BrF2O5/c1-18-8-16(27)21(24)11(10(18)3-4-20(18,29)17(28)9-25)5-14(23)12-6-15(26)13(22)7-19(12,21)2/h6-7,10-11,14,16,25,27,29H,3-5,8-9H2,1-2H3/t10-,11-,14+,16-,18-,19-,20-,21-/m0/s1
Molecular Formula | C21H25BrF2O5 |
Molecular Weight | 475.321 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 8 / 8 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionSources: http://www.ncbi.nlm.nih.gov/pubmed/3957156Curator's Comment: description was created based on several sources, including
http://www.ncbi.nlm.nih.gov/pubmed/341904
Sources: http://www.ncbi.nlm.nih.gov/pubmed/3957156
Curator's Comment: description was created based on several sources, including
http://www.ncbi.nlm.nih.gov/pubmed/341904
Halopredone (THS-201; (17,21-bis(acetyloxy)-2-bromo-6beta,9-difluoro-11beta-hydroxypregna-1,4-diene-3,20-dione; halopredone acetate; Topicon) is a highly topical corticosteroid. When it is used for intraarticular injections, the effects last longer than any other steroids which have been used, and it has less general effects. Halopredone acetate is used for arthritis and osteoarthritis (OA) patients. For RA patients, mean dose for a wrist is 12.5 mg and that for a knee is 25 mg. About 90% cases showed effectiveness and in about 45% cases the duration of effect is longer than 4 weeks. More than half cases of OA showed also improvements. It also possesses positive anti-inflammatory properties in dermatologic patients.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/3957156
for rats:
locally: 80 micrograms/pellet
s.c.: 100 mg/kg
Route of Administration:
Other
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 18:33:29 GMT 2023
by
admin
on
Fri Dec 15 18:33:29 GMT 2023
|
Record UNII |
6F4361R42W
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
Halopredone
Created by
admin on Fri Dec 15 18:33:29 GMT 2023 , Edited by admin on Fri Dec 15 18:33:29 GMT 2023
|
PRIMARY | |||
|
C166933
Created by
admin on Fri Dec 15 18:33:29 GMT 2023 , Edited by admin on Fri Dec 15 18:33:29 GMT 2023
|
PRIMARY | |||
|
57781-15-4
Created by
admin on Fri Dec 15 18:33:29 GMT 2023 , Edited by admin on Fri Dec 15 18:33:29 GMT 2023
|
PRIMARY | |||
|
CHEMBL2106520
Created by
admin on Fri Dec 15 18:33:29 GMT 2023 , Edited by admin on Fri Dec 15 18:33:29 GMT 2023
|
PRIMARY | |||
|
DTXSID901024141
Created by
admin on Fri Dec 15 18:33:29 GMT 2023 , Edited by admin on Fri Dec 15 18:33:29 GMT 2023
|
PRIMARY | |||
|
SUB08006MIG
Created by
admin on Fri Dec 15 18:33:29 GMT 2023 , Edited by admin on Fri Dec 15 18:33:29 GMT 2023
|
PRIMARY | |||
|
4077
Created by
admin on Fri Dec 15 18:33:29 GMT 2023 , Edited by admin on Fri Dec 15 18:33:29 GMT 2023
|
PRIMARY | |||
|
12788355
Created by
admin on Fri Dec 15 18:33:29 GMT 2023 , Edited by admin on Fri Dec 15 18:33:29 GMT 2023
|
PRIMARY | |||
|
6F4361R42W
Created by
admin on Fri Dec 15 18:33:29 GMT 2023 , Edited by admin on Fri Dec 15 18:33:29 GMT 2023
|
PRIMARY | |||
|
260-953-5
Created by
admin on Fri Dec 15 18:33:29 GMT 2023 , Edited by admin on Fri Dec 15 18:33:29 GMT 2023
|
PRIMARY | |||
|
100000083925
Created by
admin on Fri Dec 15 18:33:29 GMT 2023 , Edited by admin on Fri Dec 15 18:33:29 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |